New drug combo targets deadly brain tumors in first human trial
NCT ID NCT03423628
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This study tests a new drug called AZD1390 given together with radiation therapy for people with glioblastoma (a fast-growing brain cancer) or brain tumors that have spread from other cancers. It is the first time this drug is used in humans, so the main goals are to find safe doses and understand side effects. About 180 adults with these brain tumors will take part across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA MULTIFORME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBoston, Massachusetts, 02114, United States
-
Research Site
RECRUITINGBoston, Massachusetts, 02215, United States
-
Research Site
RECRUITINGNew York, New York, 10065, United States
-
Research Site
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Research Site
RECRUITINGRichmond, Virginia, 23298, United States
-
Research Site
COMPLETEDChūōku, 104-0045, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGHidaka-shi, 350-1298, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGKyoto, 606-8507, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Research Site
COMPLETEDGlasgow, G12 0YN, United Kingdom
-
Research Site
RECRUITINGLeeds, LS9 7TF, United Kingdom
-
Research Site
WITHDRAWNLondon, W1T 7HA, United Kingdom
Conditions
Explore the condition pages connected to this study.